Mycobacterium tuberculosis Rv3628 is an effective adjuvant via activation of dendritic cells for cancer immunotherapy

Recent Advances in Lipopolysaccharide Recognition Systems

(2020) Lalita Mazgaeen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Escherichia coli adhesion portion FimH functions as an adjuvant for cancer immunotherapy

(2020) Wei Zhang et al.   Nature Communications

Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts

(2019) A. Capasso et al.   Journal for ImmunoTherapy of Cancer

Adjuvant Potential of Poly-α-L-Glutamine from the Cell Wall of Mycobacterium tuberculosis

(2018) Rajesh Mani et al.   INFECTION AND IMMUNITY

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

(2018) Spencer C. Wei et al.   Cancer Discovery

Rehmannia glutinosa polysaccharide induces toll-like receptor 4 dependent spleen dendritic cell maturation and anti-cancer immunity

(2017) Li Xu et al.   OncoImmunology

Ascophyllan functions as an adjuvant to promote anti-cancer effect by dendritic cell activation

(2016) Wei Zhang et al.   Oncotarget

Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain

(2016) Woo Sik Kim et al.   Oncotarget

Enhancement of Tumor-Specific T Cell-Mediated Immunity in Dendritic Cell-Based Vaccines by Mycobacterium tuberculosis Heat Shock Protein X

(2014) I. D. Jung et al.   JOURNAL OF IMMUNOLOGY

Fucoidan Can Function as an Adjuvant In Vivo to Enhance Dendritic Cell Maturation and Function and Promote Antigen-Specific T Cell Immune Responses

(2014) Jun-O Jin et al.   PLoS One

Dendritic-Cell-Based Therapeutic Cancer Vaccines

(2013) Karolina Palucka et al.   IMMUNITY

Innate and adaptive immune cells in the tumor microenvironment

(2013) Thomas F Gajewski et al.   NATURE IMMUNOLOGY

Dendritic Cell-Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells

(2012) Y. Dang et al.   CLINICAL CANCER RESEARCH

Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation

(2012) Jun-O Jin et al.   JOURNAL OF AUTOIMMUNITY

Tumor associated regulatory dendritic cells

(2012) Yang Ma et al.   SEMINARS IN CANCER BIOLOGY

Structure of theMycobacterium tuberculosissoluble inorganic pyrophosphatase Rv3628 at pH 7.0

(2011) Stefano Benini et al.   Acta Crystallographica Section F-Structural Biology and Crystallization Communications

Rv0315, a novel immunostimulatory antigen of Mycobacterium tuberculosis, activates dendritic cells and drives Th1 immune responses

(2011) Eui-Hong Byun et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

(2010) Sarah L. Jongbloed et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Adjuvants for cancer vaccines

(2010) Thomas W. Dubensky et al.   SEMINARS IN IMMUNOLOGY

Cancer Immunology

(2008) Olivera J. Finn   NEW ENGLAND JOURNAL OF MEDICINE